HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Rheumatology
Meta-analysis
Luteolin monotherapy improves cognitive and memory impairments in rodent models of Alzheimer disease
Luteolin may improve memory and brain health in rodent models
This meta-analysis of preclinical rodent models indicates that luteolin monotherapy significantly ameliorates cognitive and memory impairmen…
A review of research suggests the compound luteolin could protect memory and reduce brain inflammation in models of Alzheimer's disease.
Frontiers
Oct 15, 2026
Drug Pipeline
Sys. Review
Luteolin suppresses neuroinflammation by modulating microglial activation and antioxidant defenses
Luteolin Shows Promise for Brain Inflammation
This systematic review examines luteolin's effects on neuroinflammation in central nervous system disorders. The evidence suggests luteolin …
A compound in celery and parsley may help calm brain inflammation, but more research is needed.
Frontiers
Jun 2, 2026
Neurology
Meta-analysis
Systematic Review: Flavonoids from Traditional Chinese Medicine Show Promise for NAFLD
Flavonoids from Chinese medicine show promise for fatty liver disease
This systematic review examines flavonoids from traditional Chinese medicine for non-alcoholic fatty liver disease. The authors report that …
A systematic review suggests flavonoids from traditional Chinese medicine may improve liver health in humans and animals by reducing fat and…
Frontiers
May 28, 2026
Drug Pipeline
Sys. Review
Review of flavonoids shows preclinical neuroprotective potential in Parkinson's disease models
Parkinson's drugs may need a new partner
This narrative review synthesizes preclinical evidence regarding flavonoids including baicalein, quercetin, apigenin, luteolin, and EGCG in …
Plant-based compounds could one day help treat Parkinson's by fixing multiple brain chemicals at once, not just dopamine.
Frontiers
Apr 18, 2026